Cover Image

Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?

This is a cross-sectional study of 29 published cases of acute myopericarditis following COVID-19 mRNA vaccination. The most common presentation was chest pain within 1-5 days after the second dose of mRNA COVID-19 vaccination. All patients had an elevated troponin. Cardiac magnetic resonance imagin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Bibhuti B. Das (Author), William B. Moskowitz (Author), Mary B. Taylor (Author), April Palmer (Author)
Format:	Book
Published:	MDPI AG, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Neuropsychiatric Disorders and COVID-19: What We Know So Far
by: Fernanda Majolo, et al.
Published: (2021)

COVID-19 Pandemic in Libya: What do we know so far?
by: Qais Gasibat, et al.
Published: (2020)

Sport and Autism: What Do We Know so Far? A Review
by: Sidney Grosprêtre, et al.
Published: (2024)

Diabetic kidney disease: what we know so far - literature review
by: Piotr Kuczyński, et al.
Published: (2024)

Autoimmune pancreatitis type 1 and type 2: what we know so far
by: Marta Piotrowska, et al.
Published: (2024)

The Effects of Economic Crisis on Health of the Serbian Population: What Do We Know So Far?
by: Natasa POPOVIC, et al.
Published: (2019)

Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far
by: Domenico Umberto De Rose, et al.
Published: (2020)

Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
by: Concetta Rafaniello, et al.
Published: (2022)

SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know So Far?
by: Taha Gul Shaikh, et al.
Published: (2022)

Cancer Nanotheranostics: What Have We Learned So Far?
by: Pedro Viana Baptista
Published: (2016)

Mental Health Implications of the COVID-19 Pandemic Among Children and Adolescents: What Do We Know so Far?
by: Listernick ZI, et al.
Published: (2021)

Unmet Needs for Family Caregivers of Elderly People With Dementia Living in Italy: What Do We Know So Far and What Should We Do Next?
by: Maria C. De Cola Stat, et al.
Published: (2017)

Cancer Epidemiology in China: What We Have Learnt So Far?
Published: (2020)

Targeting hepatocellular carcinoma: what did we discover so far?
by: Ana Filipa Brito, et al.
Published: (2016)

Monoclonal Antibodies Targeting CGRP: From Clinical Studies to Real-World Evidence-What Do We Know So Far?
by: Theodoros Mavridis, et al.
Published: (2021)

Recurrent pericarditis in an adolescent with Crohn's colitis
by: Bibhuti B Das, et al.
Published: (2020)

Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far?
by: Sophia Uddin, et al.
Published: (2022)

Tomato flu in children in India: What evidence do we have so far?
by: Parimala Mohanty, et al.
Published: (2022)

Side Effects of Misoprostol Per Rectal for Treating Postpartum Hemorrhage in Vaginal Delivery versus Cesarean Section: What Do We Know So Far?
by: Novitasari Nasution, et al.
Published: (2020)

SIFO - an insufficiently researched, but clinically significant issue. What do we know so far? Can physical activity help to relieve gastrointestinal symptoms?
by: Agata Magierska, et al.
Published: (2024)

On the Use of Concept Maps as an Assessment Tool in Science: What we have Learned so Far
by: María Araceli Ruiz Primo
Published: (2000)

Neonatologist-performed point-of-care abdominal ultrasound: What have we learned so far?
by: Archana Priyadarshi, et al.
Published: (2023)

COVID 19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis
by: Giuseppe Calcaterra, et al.
Published: (2021)

What So Special with Endometriosis Characteristics ye tWe Don't Know About?
by: Haryono Winarto
Published: (2016)

Rabies : What We Know and What We Need to Know
by: Sandhu TS
Published: (2004)

SARS-CoV-2 Myocarditis in a High School Athlete after COVID-19 and Its Implications for Clearance for Sports
by: Bibhuti B. Das
Published: (2021)

International Trade and Investment and Food Systems: What We Know, What We Don't Know, and What We Don't Know We Don't Know
by: Ashley Schram, et al.
Published: (2021)

Key Challenges in Modelling an Epidemic - What Have we Learned from the COVID-19 Epidemic so far
by: Eržen Ivan, et al.
Published: (2020)

Paediatric schistosomiasis: What we know and what we need to know.
by: Derick N M Osakunor, et al.
Published: (2018)

Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273 Vaccine
by: Abdulbaril Olagunju MD, et al.
Published: (2022)

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors
by: Laura C. Zwiers, et al.
Published: (2023)

So near yet so far away
by: R. John Aitken, Ph.D
Published: (2020)

Understanding molecular landscape of endometrial cancer through next generation sequencing: what we have learned so far?
by: SITI SYAZANI SUHAIMI, et al.
Published: (2016)

The Private Library What We Do Know, What We Don't Know, What We Ought to Know About Our Books
by: Humphreys, Arthur Lee, 1865-1946

Towards open science: what we know and what we need to know
by: Álvaro Francisco Lopes de Sousa, et al.

Cutaneous Adnexal Cysts Revisited: What We Know and What We Think We Know
by: Gürkan Kaya, et al.
Published: (2018)

Postinflammatory hyperpigmentation: what we should know
by: Rashmi Sarkar, et al.
Published: (2019)

Body Composition in Children: What Does It Tell Us So Far?
by: Odysseas Androutsos, et al.
Published: (2022)

Case report: Five patients with myocarditis after mRNA COVID-19 vaccination
by: Hiroki Murase, et al.
Published: (2022)

Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis – A Systematic Review of Population-Based Data
by: Lin YC, et al.
Published: (2023)